Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Guobing Yin
Observed name:
Yin, Guobing
Institution:
Second Affiliated Hospital of Chongqing Medical University
Observed institutions:
Second Affiliated Hospital of Chongqing Medical University,
Chongqing Medical University
ORCID:
0009-0009-5939-9531
Observed ORCID:
0009-0009-5939-9531
OpenAlex ID:
A5101200677
Circulating Tumor Microenvironment in Metastasis
2025
·
Rui Tang
, Shujuan Luo
, et al.
·
Cancer Research
·
46
TCF12 regulates exosome release from epirubicin-treated CAFs to promote ER+ breast cancer cell chemoresistance
2023
·
Yuxiang Qiu
, Xing Wang
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
·
10
Large Language Models as a Consulting Hotline for Patients With Breast Cancer and Specialists in China: Cross-Sectional Questionnaire Study
2025
·
Hui Liu
, Jialun Peng
, et al.
·
JMIR Medical Informatics
·
8
PDF
Weakened humoral immune responses of inactivated SARS‐CoV‐2 vaccines in patients with solid tumors
2022
·
Zhiwei Chen
, Peng Zhu
, et al.
·
癌症:英文版
·
6
PDF
ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
2026
·
Shanchun Chen
, Chao Chang
, et al.
·
Cancer Research
·
2
Development of a breast cancer case management information platform (BC-CMIP) module based on patient-perceived value
2022
·
Yinyin Liang
, Yan Gao
, et al.
·
Frontiers in Oncology
·
2
PDF
directional-tail-excess: a distribution-level test separating subpopulation selection from a population-wide state transition
2026
·
Xu, Ansheng
, Chen, Cheng
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Analysis code for: NET-related gene signatures in ER-positive breast cancer reflect tissue composition rather than neutrophil biology
2026
·
Xu, Ansheng
, Yu, Yang
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
An endocrine-resistance transcriptional score marks early rather than late relapse in oestrogen-receptor-positive breast cancer: analysis code
2026
·
Xu, Ansheng
, Yu, Yang
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Figure S1 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
2026
·
Shanchun Chen
, Chao Chang
, et al.
Figure S6 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
2026
·
Shanchun Chen
, Chao Chang
, et al.
Figure S9 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
2026
·
Shanchun Chen
, Chao Chang
, et al.
Figure S2 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
2026
·
Shanchun Chen
, Chao Chang
, et al.
Figure S5 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
2026
·
Shanchun Chen
, Chao Chang
, et al.
Figure S8 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
2026
·
Shanchun Chen
, Chao Chang
, et al.
Figure S5 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
2026
·
Shanchun Chen
, Chao Chang
, et al.
Figure S4 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
2026
·
Shanchun Chen
, Chao Chang
, et al.
Figure S6 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
2026
·
Shanchun Chen
, Chao Chang
, et al.
Figure S7 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
2026
·
Shanchun Chen
, Chao Chang
, et al.
Supplementary Table 1 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
2026
·
Shanchun Chen
, Chao Chang
, et al.
Figure S3 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
2026
·
Shanchun Chen
, Chao Chang
, et al.
Supplementary Table 2 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
2026
·
Shanchun Chen
, Chao Chang
, et al.
Figure S3 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
2026
·
Shanchun Chen
, Chao Chang
, et al.
Supplementary Table 3 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
2026
·
Shanchun Chen
, Chao Chang
, et al.
Figure S2 from ACSL5 Mediates Adaptation to the Palmitic Acid–Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis
2026
·
Shanchun Chen
, Chao Chang
, et al.
Show more works
View as search
Works count:
37
Citation count:
74
H-index:
4
I10-index:
2
Year
Topic
Type